• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Chesapeake IRB, Schulman IRB merge to create Advarra

Chesapeake IRB, Schulman IRB merge to create Advarra

November 8, 2017
CenterWatch Staff

Chesapeake IRB and Schulman IRB, two respected institutional review boards (IRBs), have combined to create Advarra, a premier provider of IRB, institutional biosafety committee (IBC) and research compliance services in North America. The new organization will leverage mutual strengths in technology, regulatory expertise and customer service to serve the increasingly complex needs associated with research.

“By coming together as Advarra, we are merging the highest quality review organizations in the industry,” said Jeffrey Wendel, president and CEO of Chesapeake IRB. “Through a customer-centric integration we will be able to provide additional scope and capacity while maintaining the highest standards of research review and unparalleled efficiency. We are delighted to come together with a like-minded organization that places the same emphasis on integrity and quality.”

“We are tremendously excited about this strategic combination that will allow us to further develop and accelerate innovation across our portfolio of IRB services, IBC services and research compliance consulting,” said Michael Woods, president and CEO at Schulman IRB. “This also enables us to leverage our mutual technology capabilities and robust regulatory expertise to speed study start-up. Together, we are even better positioned to deliver unparalleled human subject protection and oversight with exceptional client service.”

The combined regulatory expertise and technology-enabled solutions of Chesapeake IRB and Schulman IRB will also further support and advance service offerings to academic medical centers and hospital systems, especially in light of recent regulatory mandates for single IRB review.

“By leveraging the best attributes of our respective organizations, we will provide a singular focus on increasing the efficiency and delivery of IRB services that will resonate with sponsors, CROs and research institutions alike,” said Wendel.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing